BRAINSTORM CELL THERAPEUTICS INC. Contracts & Agreements

Amendment No. 1 dated April 2, 2024 to the Distribution Agreement dated August 9, 2024 by and among Brainstorm Cell Therapeutics Inc., Leerink Partners LLC and Raymond James &... (Filed With SEC on April 2, 2024)

Employment Agreement, dated as of December 23, 2012 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (Filed With SEC on April 1, 2024)

Amendment No. 1 to Employment Agreement, effective as of March 1, 2015 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (Filed With SEC on April 1, 2024)

Amendment No. 2 to Employment Agreement, effective as of April 1, 2019 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (Filed With SEC on April 1, 2024)

Amendment No. 3 to Employment Agreement, effective as of May 1, 2020 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (Filed With SEC on April 1, 2024)

Amendment No. 4 to Employment Agreement, effective as of August 1, 2022 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (Filed With SEC on April 1, 2024)

Form of Common Warrant (Filed With SEC on July 19, 2023)

Form of Securities Purchase Agreement (Filed With SEC on July 19, 2023)

Placement Agency Agreement, dated as of July 17, 2023, by and between the Company and the placement agent party thereto (Filed With SEC on July 19, 2023)

Description of the Companys Securities (Filed With SEC on March 30, 2023)

Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on January 4, 2023)

Separation Agreement, effective January 20, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Ralph Kern (Filed With SEC on January 4, 2023)

Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on September 22, 2022)

Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan (Filed With SEC on March 28, 2022)

Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan (Filed With SEC on November 15, 2021)

Offer letter, dated May 26, 2020, by and between Brainstorm Cell Therapeutics Inc. and Stacey Lindborg (Filed With SEC on February 4, 2021)

Amended and Restated Distribution Agreement, dated September 25, 2020, by and among Brainstorm Cell Therapeutics Inc., SVB Leerink LLC and Raymond James & Associates, Inc (Filed With SEC on September 25, 2020)

Offer Letter by and between Brainstorm Cell Therapeutics Inc. and Anthony Waclawski (Filed With SEC on September 3, 2020)

Amendment to Chaim Lebovits Employment Agreement (Filed With SEC on August 5, 2020)

Amendment to Uri Yablonka Employment Agreement (Filed With SEC on August 5, 2020)

Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and David Setboun (Filed With SEC on April 3, 2020)

Common Stock Purchase Warrant for the purchase of Common Stock, issued March 6, 2020 by Brainstorm Cell Therapeutics Inc. to Abbhi Investments, LLC (Filed With SEC on March 6, 2020)

Securities Purchase Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and AI Fund 1 LLC (Filed With SEC on March 6, 2020)

Distribution Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (Filed With SEC on March 6, 2020)

Offer letter, dated September 5, 2019, by and between Brainstorm Cell Therapeutics Inc. and Preetam Shah (Filed With SEC on November 14, 2019)

Form of Warrant (Filed With SEC on August 2, 2019)

Warrant Exercise Agreement (Filed With SEC on August 2, 2019)

Distribution Agreement, dated June 11, 2019, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (Filed With SEC on June 11, 2019)

Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and Arturo Araya effective August 28, 2018 (Filed With SEC on March 29, 2019)

Amendment No. 2 to 2014 Stock Incentive Plan (Filed With SEC on November 30, 2018)

Amendment No. 2 to 2014 Global Share Option Plan (Filed With SEC on November 30, 2018)

Share Cap Agreement (Filed With SEC on July 23, 2018)

Form of Warrant (Filed With SEC on June 7, 2018)

Warrant Exercise Agreement (Filed With SEC on June 7, 2018)

Leak-Out Agreement (Filed With SEC on June 7, 2018)

Restricted Stock Award Agreement under the Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan, regarding November 20, 2017 grant to Eyal Rubin (Filed With SEC on March 8, 2018)

Notice of Award - CLIN2: Partnering Opportunity for Clinical Trial Stage Projects California Institute for Regenerative Medicine, August 25, 2017 (Filed With SEC on March 8, 2018)

2017 Amendment of Warrants and Subscription Agreement dated November 2, 2017 by and among Brainstorm Cell Therapeutics Inc., ACCBT Corp. and ACC International Holdings Ltd (Filed With SEC on November 3, 2017)

Employment Agreement by and between Brainstorm Cell Therapeutics Ltd. and Eyal Rubin, dated October 31, 2017 (Filed With SEC on November 3, 2017)

Brainstorm Cell Therapeutics Inc. Third Amendment to the Second Amended and Restated Director Compensation Plan dated July 13, 2017 (Filed With SEC on October 17, 2017)

Restricted Stock Award Agreement under the Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan, regarding July 26, 2017 grant to Chaim Lebovits (Filed With SEC on October 17, 2017)

Second Amendment to Employment Agreement dated July 26, 2017 between the Company and Chaim Lebovits (Filed With SEC on October 17, 2017)

Brainstorm Cell Therapeutics Inc. 2nd Amendment to the Second Amendedand Restated Director Compensation Plan (adopted February 26, 2017) (Filed With SEC on March 29, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on March 6, 2017)

AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATEDRESEARCH AND LICENSE AGREEMENT (Filed With SEC on March 9, 2016)

AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED RESEARCH ANDLICENSE AGREEMENT (Filed With SEC on March 9, 2016)

FirstAmendment to Employment Agreement (Filed With SEC on March 9, 2016)

FirstAmendment to Employment Agreement (Filed With SEC on November 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on September 28, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 3, 2015)

BRAINSTORM CELL THERAPEUTICS INC. Nonstatutory Stock Option Agreement (Filed With SEC on August 3, 2015)

SEPARATION AGREEMENT (Filed With SEC on May 14, 2015)

Brainstorm Cell Therapeutics Inc. 1st Amendment to the SecondAmended and Restated Director Compensation Plan (adopted April 29, 2015) (Filed With SEC on May 14, 2015)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2015)

COMMON STOCK PURCHASE WARRANT BRAINSTORMCELL THERAPEUTICS INC. (Filed With SEC on January 8, 2015)

SUBJECTTO MAXIM COMMITMENT COMMITTEE APPROVAL (Filed With SEC on January 8, 2015)

WARRANT EXERCISE AGREEMENT (Filed With SEC on January 8, 2015)

BRAINSTORM CELLTHERAPEUTICS INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on November 4, 2014)

BRAINSTORM CELLTHERAPEUTICS INC. Nonstatutory Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on November 4, 2014)

BRAINSTORM CELLTHERAPEUTICS INC. Restricted Stock Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on November 4, 2014)

BRAINSTORM CELL THERAPEUTICS INC. 2014 GLOBAL SHARE OPTION PLAN OPTIONAGREEMENT FOR OPTIONS GRANTED UNDER SECTION 102(b)(2) OF THE ISRAELI INCOME TAX ORDINANCE TO EMPLOYEES,... (Filed With SEC on November 4, 2014)

BRAINSTORM CELLTHERAPEUTICS INC. 2014 STOCK INCENTIVEPLAN (Filed With SEC on August 15, 2014)

BRAINSTORM CELL THERAPEUTICS INC. 2014 GLOBAL SHARE OPTION PLAN (Filed With SEC on August 15, 2014)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on August 12, 2014)

WARRANT REDEMPTION AGREEMENT (Filed With SEC on August 12, 2014)

WAIVER REGARDING ANTI-DILUTION May __, 2014 (Filed With SEC on August 12, 2014)

AMENDMENT OF WARRANTS May 19, 2014 (Filed With SEC on August 12, 2014)

Brainstorm Cell Therapeutics Inc. Second Amended and Restated DirectorCompensation Plan (adopted July 9, 2014) (Filed With SEC on July 10, 2014)

COMMON STOCK PURCHASE WARRANT BRAINSTORMCELL THERAPEUTICS INC. (Filed With SEC on June 19, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 13, 2014)

COMMON STOCK PURCHASE WARRANT BRAINSTORMCELL THERAPEUTICS INC. (Filed With SEC on June 13, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 13, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on June 10, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on June 9, 2014)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on May 13, 2014)

THIS WARRANT AND THE SHARES OF COMMONSTOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONSON TRANSFERSET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on May 13, 2014)

BRAINSTORM CELL THERAPEUTICS INC. 23,529,411 Units Each Unit Consisting of One Share ofCommon Stock and 0.75 of one Warrant to PurchaseOne Share of Common Stock UNDERWRITING... (Filed With SEC on August 13, 2013)

COMMON STOCK PURCHASE WARRANT brainstormcell therapeutics inc. (Filed With SEC on August 13, 2013)

BRAINSTORM CELL THERAPEUTICS INC. [ __________ ] Units Each Unit Consisting of One Share ofCommon Stock and [ ____ ]of one Warrant toPurchase One Share of Common Stock... (Filed With SEC on August 6, 2013)

COMMON STOCK PURCHASE WARRANT brainstormcell therapeutics inc. (Filed With SEC on August 6, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 9, 2013)

THIS WARRANT AND THE SHARES OF COMMONSTOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONSON TRANSFER SET FORTH IN SECTION 4 OF THISWARRANT (Filed With SEC on May 9, 2013)

THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on March 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on January 28, 2013)

COMMON STOCK PURCHASE WARRANT brainstorMcell therapeutics inc. (Filed With SEC on June 29, 2012)

CONSULTING AGREEMENT (Filed With SEC on June 29, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 29, 2012)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on June 29, 2012)

WarrantAmendment Agreement May10, 2012 (Filed With SEC on May 11, 2012)

ASSIGNMENT AGREEMENT (Filed With SEC on February 3, 2012)

FIRST AMENDMENTTO AGREEMENT (Filed With SEC on February 3, 2012)

THIS WARRANTAND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARESUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on February 3, 2012)

Amended and Restated Executive Director Agreement (Filed With SEC on November 16, 2011)

CLINICAL TRIAL AGREEMENT (Filed With SEC on August 15, 2011)

Amendment to the Clinical Trial Agreement (Filed With SEC on August 15, 2011)

Brainstorm Cell Therapeutics Inc. Director Compensation Plan (adopted June 27, 2011) (Filed With SEC on August 15, 2011)

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on August 15, 2011)

BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the __ day of___ 2011 (Filed With SEC on August 15, 2011)

BrainStorm Cell Therapeutics Inc. Restricted Stock Agreement Granted Under 2005 U.S. Stock Option and Incentive Plan (Filed With SEC on August 15, 2011)

Settlement and Waiver Agreement Made as of this 25th day of July, 2011 By and among (Filed With SEC on July 28, 2011)

BRAINSTORM CELL THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 31, 2011)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 31, 2011)

BRAINSTORM CELL THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 31, 2011)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 31, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on August 16, 2010)

BRAINSTORMCELL THERAPEUTICS INC. SUBSCRIPTIONAGREEMENT (Filed With SEC on February 1, 2010)

THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH INSECTION 4 OF THIS WARRANT (Filed With SEC on February 1, 2010)

Amendment (Filed With SEC on August 24, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on February 21, 2008)

TERMINATION AGREEMENT (Filed With SEC on December 20, 2007)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 5, 2007)

BRAINSTORM CELL THERAPEUTICS, INC. Common Stock Purchase Warrant (Filed With SEC on July 5, 2007)

SECURITY HOLDERS AGREEMENT (Filed With SEC on July 5, 2007)

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on March 12, 2007)

Category

Industry

Companies

Contracts

BRAINSTORM CELL THERAPEUTICS INC. Contracts & Agreements